Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (233)	1/13/1998 9:34:00 PM
From: GuinnessGuy	Read Replies (1) \| Respond to of 1321

Ian, From what I've seen so far, Geron won't have a competitive drug approved in less than 3 years, if ever. Hey, I bought QLTIF some six or seven years ago and look how far they have come[tongue firmly in cheek]. Yes, I agree, this announcement by Geron is not going to lead to anything anytime soon. But look at the press that this story has gotten. From the Geron thread in SI someone said that this was the lead story on one of the major network's nightly news programs. And also was mentioned that 20/20 would be doing a piece on it Friday. Looks like a media circus is developing around this one so I wouldn't be surprised to see the momentum geeks pile on. Wouldn't hold this one past Friday at 3:59pm EST though. Kind of reminds me of the 'Cold Fusion' story. That one also had some roots here in Texas(Texas A&M). Let's at least hope that this isn't the same sort of bad science. Craig